Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.31 Insider Own0.10% Shs Outstand174.16M Perf Week4.63%
Market Cap196.80M Forward P/E- EPS next Y-0.35 Insider Trans40.27% Shs Float149.51M Perf Month-9.60%
Income-52.10M PEG- EPS next Q-0.14 Inst Own40.90% Short Float19.53% Perf Quarter-9.60%
Sales47.80M P/S4.12 EPS this Y16.90% Inst Trans11.20% Short Ratio14.72 Perf Half Y-27.56%
Book/sh-0.40 P/B- EPS next Y40.70% ROA-24.20% Target Price1.86 Perf Year-28.93%
Cash/sh0.78 P/C1.45 EPS next 5Y- ROE99.10% 52W Range0.78 - 2.75 Perf YTD-42.64%
Dividend- P/FCF- EPS past 5Y-4.20% ROI-83.50% 52W High-62.18% Beta1.00
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin60.90% 52W Low33.33% ATR0.10
Employees185 Current Ratio4.50 Sales Q/Q67.90% Oper. Margin- RSI (14)45.58 Volatility8.54% 8.17%
OptionableYes Debt/Eq- EPS Q/Q48.30% Profit Margin- Rel Volume0.74 Prev Close1.13
ShortableYes LT Debt/Eq- EarningsNov 06 AMC Payout- Avg Volume1.98M Price1.04
Recom2.80 SMA20-8.07% SMA50-0.87% SMA200-28.65% Volume1,462,442 Change-7.96%
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Dec-10-12Reiterated Aegis Capital Buy $25 → $35
Dec-07-12Reiterated Aegis Capital Buy $25 → $35
Jul-12-11Initiated MKM Partners Buy $23
Apr-25-11Reiterated Wedbush Outperform $12 → $18
Apr-18-11Reiterated Canaccord Genuity Buy $11 → $18
Dec-29-10Reiterated Wedbush Outperform $7 → $10
Jul-20-10Initiated Wedbush Outperform $5
Feb-03-09Initiated Rodman & Renshaw Mkt Outperform $3.50
Nov-06-08Initiated Rodman & Renshaw Mkt Outperform $3.50
Dec-04-14 07:00AM  Amarin to Present at the 25th Annual Oppenheimer Healthcare Conference Marketwired
Nov-19-14 01:04PM  AMARIN CORP PLC\UK Financials EDGAR Online Financials -5.30%
06:12AM  Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% Zacks
Nov-17-14 09:00AM  Amarin Announces Presentation of MARINE and ANCHOR Analyses at the American Heart Association Scientific Sessions Showing Vascepa(R) Significantly Reduced Remnant-Like Particle Cholesterol in Hypertriglyceridemic Patients Marketwired +12.66%
Nov-14-14 04:43PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
Nov-13-14 07:00AM  Rick Harrison of Television's "Pawn Stars(R)" Takes His Patient-Care Message to AHA Scientific Sessions to Raise Awareness of Very High Triglycerides as Part of National Campaign Marketwired +6.98%
Nov-06-14 04:02PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:00PM  Amarin Reports Third Quarter 2014 Financial Results and Provides Update on Operations Marketwired
07:07AM  Q3 2014 Amarin Corporation PLC Earnings Release - After Market Close CCBN
Nov-05-14 04:45PM  Amarin to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, November 6, 2014 Accesswire +6.39%
Oct-30-14 07:00AM  Amarin to Report Third Quarter 2014 Results and Host Conference Call on November 6, 2014 Marketwired
Oct-16-14 08:01AM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia EDGAR Online +6.06%
Sep-16-14 06:07AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
01:00AM  Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study Marketwired
Sep-15-14 03:45PM  Amarin Plunges after the FDA Denies Vascepa SPA Appeal Zacks
Sep-12-14 04:51PM  Week Concludes With S&P 500 Below 2,000; Dow Below 17,000 Benzinga -17.68%
03:59PM  Dow Falls Over 100 Points; Ulta Salon Shares Jump After Earnings Report Benzinga
02:02PM  Conversant Shares Rise On Acquisition News; Health Care REIT Drops Benzinga
11:39AM  Why Amarin (AMRN) Stock Is Plummeting Today at TheStreet
11:26AM  Markets Drop; Darden Adjusted Profit Beats Street View Benzinga
09:43AM  Third Time Was No Charm, FDA Denies Amarin Vascepa SPA Appeal at TheStreet
09:00AM  Amarin Provides Update on ANCHOR Trial SPA Agreement Rescission Appeal Marketwired
Sep-09-14 11:47AM  Notice to Investors in Amarin Corp. plc's (AMRN) July 10, 2013 Public Offering: Wolf Popper LLP Announces Anticipated Filing of Amended Complaint Against Amarin Corp. plc (NASDAQ: AMRN) PR Newswire
Sep-03-14 07:00AM  Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference Marketwired
06:45AM  Is Amarin Corporation (AMRN) Stock a Solid Choice Right Now? Zacks
Aug-07-14 04:18PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:01PM  Amarin Reports Second Quarter 2014 Financial Results and Provides Update on Operations Marketwired
Aug-05-14 07:00AM  Amarin to Report Second Quarter 2014 Results and Host Conference Call on August 7, 2014 Marketwired
Jul-31-14 12:01PM  Amarin Moves Higher On Speculation Of Special Protocol Assessment Benzinga +13.21%
09:02AM  Amarin Shocker: There's a Reason to be Bullish Right Now at TheStreet
Jul-21-14 04:38PM  Amarin: Will The Lamb Of Ireland Bleat Or The Lion Of The People Roar? at Seeking Alpha
Jul-10-14 04:31PM  AMARIN CORP PLC\UK Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-27-14 08:35AM  Amarin Scrapes The Bottom Of The Barrel at Seeking Alpha
Jun-25-14 06:30AM  Rick Harrison of Television's "Pawn StarsĀ®" Discusses His Revelations on Seeking Treatment for His Very High Triglycerides in National Awareness Campaign PR Newswire
Jun-24-14 10:28AM  Of These 3 Battleground Biotech Stocks, 1 Is a Buy
Jun-19-14 07:00AM  Mutations That Prevent Heart Attacks Upend The Search For New Drugs at Forbes
Jun-13-14 08:08AM  Update-Moody's downgrades Novasep's probability of default rating to Caa1-PD from B3-PD; outlook changed to negative Reuters
08:02AM  Novasep Holding SAS -- Moody's downgrades Novasep's probability of default rating to Caa1-PD from B3-PD; outlook changed to negative at Moody's
Jun-12-14 10:21AM  Stagnant Sales An Ominous Sign For Amarin at Seeking Alpha
Jun-11-14 07:03AM  Amarin announces Vascepa case study publication theflyonthewall.com
07:00AM  Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa(R) Marketwired
Jun-04-14 08:00AM  Amarin to Present at the Goldman Sachs 2014 Global Healthcare Conference Marketwired
May-29-14 08:00AM  Amarin to Present at the Jefferies 2014 Global Healthcare Conference Marketwired
May-21-14 05:02PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl EDGAR Online
May-15-14 02:37PM  Why Amarin (AMRN) Stock Is Plummeting Today at TheStreet -9.87%
01:02PM  Why Amarin Corporation PLC Shares Tumbled at Motley Fool
06:15AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:00AM  Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes GlobeNewswire
May-12-14 06:16AM  Amarin downgraded to Neutral from Buy at Citigroup at theflyonthewall.com
May-09-14 04:09PM  Amarin downgraded to Neutral from Buy at Citigroup at theflyonthewall.com
12:20PM  Amarin's (AMRN) CEO John Thero on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
09:01AM  Health Care Stocks to Watch Today: Amarin Corporation plc, Jazz Pharmaceuticals, and Vanda Pharmaceuticals at Motley Fool
07:07AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
07:07AM  Q1 2014 Amarin Corporation PLC Earnings Release - Before Market Open CCBN
07:00AM  Amarin Reports First Quarter 2014 Financial Results and Provides Update on Operations GlobeNewswire
May-06-14 12:39PM  FDA Approves New Omega-3 Supplement at Forbes
May-05-14 08:00AM  Amarin to Report First Quarter 2014 Results and Host Conference Call on May 9, 2014 GlobeNewswire
May-02-14 08:13AM  Amarin to present data showing Vascepa significantly reduced ApoC-III levels at theflyonthewall.com
08:00AM  Amarin Announces Presentation of New MARINE and ANCHOR Post-Hoc Analyses at National Lipid Association Annual Scientific Sessions Showing Vascepa(R) Significantly Reduced Apolipoprotein C-III Levels GlobeNewswire
Apr-15-14 09:44AM  The Supreme Court Will Decide the Fate of a Blockbuster at Motley Fool
Apr-10-14 02:30PM  More Trouble Looming for Amarin Corporation? at Motley Fool
Apr-06-14 12:13PM  Partner Signed! Is Amarin's Turnaround Beginning? at Motley Fool
Apr-01-14 03:21PM  Amarin Takes Step 1, Of A Million, To Right Its Ship at Seeking Alpha +6.08%
02:31PM  Can This Drive Growth for Amarin Corporation plc? at Motley Fool
12:21PM  Story Stocks from Briefing.com Briefing.com
12:53AM  Amarin: How The Co-Promotion Agreement With Kowa Affects Required Sales Targets at Seeking Alpha
Mar-31-14 07:09PM  On The Fly: After Hours Movers at theflyonthewall.com
04:41PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements EDGAR Online
04:30PM  Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules GlobeNewswire
Mar-28-14 06:00AM  3 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet
Mar-21-14 02:31PM  Better Chance of Making a Comeback: Amarin plc or VIVUS, Inc.? at Motley Fool
07:00AM  Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks' at TheStreet
Mar-14-14 04:46PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
Mar-06-14 05:01PM  AMARIN CORP PLC\UK Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibi EDGAR Online
Mar-04-14 05:35PM  If You Can't Make Your Drug a Blockbuster, Sue Your Competitor at Motley Fool
06:14AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
Feb-28-14 02:17PM  Can Amarin Corporation PLC Stop Burning Cash? at Motley Fool
Feb-27-14 10:20PM  Amarin Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
08:30PM  Amarin Sues FDA Over Exclusivity for Fish Oil Pill at Bloomberg
04:07PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:01PM  Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations GlobeNewswire
07:07AM  Q4 2013 Amarin Corporation PLC Earnings Release - After Market Close CCBN
Feb-26-14 02:16PM  Amarin Is Likely Now A Vortex Where Your Money Will Go To Die at Seeking Alpha
Feb-25-14 02:54PM  What Now For Amarin? at Seeking Alpha
09:31AM  Two Years Less Exclusivity Is the Least of Amarin's Issues at Motley Fool
Feb-24-14 04:20PM  Amarin's Vascepa Gets 3-Year Exclusivity Zacks
07:59AM  Amarin Loses Bid for Vascepa 5-Year Market Exclusivity at TheStreet
06:00AM  Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014 GlobeNewswire
Feb-21-14 10:05PM  Amarin Given 3-Year Exclusivity for Vascepa at Motley Fool
04:12PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
04:01PM  Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules GlobeNewswire
Feb-17-14 03:37PM  3 Biotech Stocks to Avoid: Amarin, Dendreon, and Prosensa at Motley Fool
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.